NCT06095089 2026-02-17
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer
Janssen Research & Development, LLC
Phase 1 Recruiting
Clinical Trials
9 trialsNCT07115446 2025-12-05
Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer
Hansoh BioMedical R&D Company
Phase 1 Recruiting
NCT07198633 2025-09-30
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06984159 2025-05-22
The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT03936218 2025-04-17
Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer
Eurofarma Laboratorios S.A.
Phase 3 Completed
NCT05942001 2025-02-19
Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Recruiting
NCT06490328 2024-07-08
Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer
Dongkook Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT06006104 2023-08-23
Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Unknown
NCT03971110 2022-12-16
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
AstraZeneca
Phase 4 Terminated